ArticleJournal of inflammation research2026
Early Pan-Immune-Inflammation Value Trajectories are Associated with Unfavorable Neurological Outcomes After Extracorporeal Cardiopulmonary Resuscitation.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neurological outcome is key to extracorporeal cardiopulmonary resuscitation (ECPR) benefit. However, the prognostic relevance of early PIV dynamics after ECPR remains poorly characterized. Methods: We conducted an exploratory retrospective single-center study of 107 ECPR patients with at least three valid complete blood count (CBC) measurements within 24 h of extracorporeal membrane oxygenation (ECMO) pump-on. The primary outcome was an unfavorable neurological outcome at hospital discharge, defined as Cerebral Performance Category (CPC) 3-5. Latent class mixed models (LCMMs) were used to identify early pan-immune-inflammation value (PIV) trajectory groups, and multivariable logistic regression evaluated their association with the outcome. Incremental predictive performance was explored using leakage-controlled nested cross-validation in which trajectory modeling was repeated within each outer training fold. Results: Among 107 included patients, 53 had an unfavorable neurological outcome at hospital discharge. Two distinct early PIV trajectory patterns were identified in this selected cohort: a high-baseline decreasing class (n=68) and a low-baseline rising class (n=39). The low-baseline rising class had a significantly higher rate of unfavorable neurological outcome than the high-baseline decreasing class (69.2% vs 38.2%, P=0.004). In the fully adjusted model, the low-baseline rising trajectory was associated with significantly higher odds of unfavorable neurological outcome compared with the high-baseline decreasing trajectory (odds ratio 5.70, 95% confidence interval 1.73-18.81, P=0.004). In an internal exploratory comparison, adding the trajectory class to the clinical risk model increased the area under the receiver operating characteristic curve from 0.746 to 0.812, but the bootstrap 95% CI for the AUC increment crossed zero. Conclusion: Two exploratory early PIV trajectory groups were identified in this selected cohort. The low-baseline rising pattern was associated with a higher probability of CPC-defined unfavorable neurological outcome at hospital discharge in this selected single-center cohort. Although trajectory information numerically improved internal predictive performance, the incremental improvement was uncertain and requires external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.